PMID- 31803601 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20220411 IS - 2230-8210 (Print) IS - 2230-9500 (Electronic) IS - 2230-9500 (Linking) VI - 23 IP - 5 DP - 2019 Sep-Oct TI - The Clinical Spectrum of Fibrocalculous Pancreatic Diabetes in Kashmir Valley and Comparative Study of the Clinical Profile of Fibrocalculous Pancreatic Diabetes and Type 2 Diabetes Mellitus. PG - 580-584 LID - 10.4103/ijem.IJEM_297_19 [doi] AB - BACKGROUND: Fibrocalculous pancreatic diabetes (FCPD) is a secondary form of diabetes, described from several tropical countries, including India. We described the existence of this entity in the subtropical region-the Kashmir valley of the Indian subcontinent and compared the clinical characteristics of these patients with type 2 diabetes mellitus (T2DM) patients. AIM: The present study aimed to compare the clinical characteristics of patients with FCPD and those with T2DM to identify the characteristics distinctive of FCPD. MATERIALS AND METHODS: A total of 124 patients with FCPD were compared with 124 patients with T2DM matched for age and duration of diabetes. Biochemical parameters and microvascular and macrovascular complications were assessed in all patients. Multivariate regression analyses were performed to study the determinants of microvascular complications in both groups. RESULTS: FCPD patients had significantly lower serum cholesterol, serum triglyceride, and serum calcium levels but higher glycosylated hemoglobin levels compared to T2DM patients. FCPD participants were significantly leaner. The prevalence of retinopathy, neuropathy, and nephropathy was similar between the two. Five T2DM patients had documented cardiovascular disease compared to one in FCPD patients (P < 0.05). Multiple logistic regression analysis revealed glycosylated hemoglobin and duration of diabetes to be significantly associated with retinopathy and nephropathy in T2DM. Among FCPD patients, glycosylated hemoglobin showed a strong association with retinopathy as well as nephropathy. BMI showed a significant negative association with nephropathy in FCPD patients. Age and age at onset showed a strong association with neuropathy in FCPD patients while the duration of diabetes showed the association with neuropathy (P = 0.015) in T2DM. CONCLUSION: There are several differences in the phenotype, biochemical parameters, and prevalence of diabetic complications between patients with FCPD and T2DM. CI - Copyright: (c) 2019 Indian Journal of Endocrinology and Metabolism. FAU - Bhat, Javaid Ahmad AU - Bhat JA AD - Department of Endocrinology, Consultant Health, Srinagar, Jammu and Kashmir, India. FAU - Bhat, Moomin Hussain AU - Bhat MH AD - Department of Endocrinology, Sher-i-Kashmir Institute of Medical Sciences, Srinagar, Jammu and Kashmir, India. FAU - Misgar, Raiz Ahmad AU - Misgar RA AD - Department of Endocrinology, Sher-i-Kashmir Institute of Medical Sciences, Srinagar, Jammu and Kashmir, India. FAU - Bashir, Mir Iftikhar AU - Bashir MI AD - Department of Endocrinology, Sher-i-Kashmir Institute of Medical Sciences, Srinagar, Jammu and Kashmir, India. FAU - Wani, Arshad Iqbal AU - Wani AI AD - Department of Endocrinology, Sher-i-Kashmir Institute of Medical Sciences, Srinagar, Jammu and Kashmir, India. FAU - Masoodi, Shariq Rashid AU - Masoodi SR AD - Department of Endocrinology, Sher-i-Kashmir Institute of Medical Sciences, Srinagar, Jammu and Kashmir, India. FAU - Ashraf, Hamid AU - Ashraf H AD - Department of Endocrinology, Rajiv Gandhi Centre for Diabetes and Endocrinology, AMU, Aligarh, Uttar Pradesh, India. FAU - Sood, Mona AU - Sood M AD - Department of Endocrinology, Sher-i-Kashmir Institute of Medical Sciences, Srinagar, Jammu and Kashmir, India. LA - eng PT - Journal Article PL - India TA - Indian J Endocrinol Metab JT - Indian journal of endocrinology and metabolism JID - 101555690 PMC - PMC6873263 OTO - NOTNLM OT - Coronary artery disease OT - diabetic nephropathy OT - diabetic retinopathy OT - fibrocalculous pancreatic diabetes OT - type 2 diabetes mellitus COIS- There are no conflicts of interest. EDAT- 2019/12/06 06:00 MHDA- 2019/12/06 06:01 PMCR- 2019/09/01 CRDT- 2019/12/06 06:00 PHST- 2019/12/06 06:00 [entrez] PHST- 2019/12/06 06:00 [pubmed] PHST- 2019/12/06 06:01 [medline] PHST- 2019/09/01 00:00 [pmc-release] AID - IJEM-23-580 [pii] AID - 10.4103/ijem.IJEM_297_19 [doi] PST - ppublish SO - Indian J Endocrinol Metab. 2019 Sep-Oct;23(5):580-584. doi: 10.4103/ijem.IJEM_297_19.